Skip to main content

Advertisement

Figure 1 | Alzheimer's Research & Therapy

Figure 1

From: Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study

Figure 1

Summary of patient screening. Aβ: β-amyloid; CSF: Cerebrospinal fluid; MMSE: Mini Mental State Examination; MRI: Magnetic resonance imaging; P-tau: Phosphorylated tau. 1Three patients were screened twice therefore 29 screening evaluations were conducted. 2Three patients received GSK933776 at two dose levels; therefore, GSK933776 was administered 18 times.

Back to article page